HOME >> BIOLOGY >> NEWS
New Guidelines To Improve Public Understanding

February 27, 1998, WASHINGTON, DC -- Feeling more confused than enlightened after reading or hearing about the latest dietary study du jour? Newly-released guidelines, based on an advisory group convened by the Harvard School of Public Health and the International Food Information Council (IFIC) Foundation, aim to help the public have a better understanding of emerging nutrition, food safety and health science.

"Improving Public Understanding: Guidelines for Communicating Emerging Science on Nutrition, Food Safety and Health" suggests both broad and specific "guiding principles" for those involved in communicating emerging science, from scientists and journal editors to public information officers, journalists, and industry, consumer and other interest groups.

"There is no expectation that every story will include all or most of the suggested information. Instead these guidelines can help communicators focus on the most vital information the public should have in order to form the most useful net impression of a particular study's findings," said Harvey V. Fineberg, MD, PhD, MPH, provost of Harvard University and Sylvia Rowe, president of the IFIC Foundation, co-authors of a commentary published in a recent issue of the Journal of the National Cancer Institute (JNCI).

As one of the key participants in the advisory group, ABC-News' Dr. Timothy Johnson commented, "I think what the public wants is for us to be honest with each study as it comes along and try to put it into perspective, but keep reminding people that it's the totality of evidence as it unfolds that warrants their attention."

In addition to publication in JNCI (2/4/98), the guidelines were reported in the Journal of the American Medical Association (JAMA, 2/11/98).

Reprints of the JNCI article and JAMA report and a booklet version of "Improving Public Understanding: Guidelines for Communicating Emerging Science on Nutrition, Food Safety, and Health" are available from
'"/>

Contact: Amelia Steiner, Kara Cosby, Alison Esser
esser@ific.health.org
202/296-6540
International Food Information Council Foundation
24-Mar-1998


Page: 1 2

Related biology news :

1. Guidelines outline evaluation of children with global developmental delay
2. Multi-Center Study Provides Guidelines For Genetic Testing In Women With Breast Cancer: BRCA Abnormalities Multiply Risk Of Ovarian Cancer
3. Guidelines For Next Generation Of Environmental Policy
4. Guidelines For Human Germ-Line Interventions Topic Of AAAS Forum
5. Improved nutrition could reduce malaria burden worldwide
6. Improved nutrition could prevent more than half of the worlds child deaths annually
7. Improved crop production and fewer greenhouse gases
8. Improved medical treatment of serious heart problems focus of UH-led group
9. Improved estimates of population extinction risk (Harding and McNamara)
10. Improved guidance systems for missiles will reduce collateral damage
11. Food allergy reactions in schools: Improvements needed to reduce and respond

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Guidelines Improve Public Understanding

(Date:5/20/2015)... 20, 2015 ... announced the addition of the  "5-year ... Recognition Market"  report to their offering.  ... service analyses trends in the iris ... commercial sectors, globally. Despite hardware pricing ...
(Date:5/19/2015)... , May 19, 2015 ... has announced the addition of the  "Genetic ... offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent ... an in-depth analysis of the current and ... of gene-based tests, their working principles and ...
(Date:5/11/2015)... 2015  Synaptics Incorporated (NASDAQ: SYNA ), ... announced the appointment of Wajid Ali ... reporting to Rick Bergman , President and ... Officer, Kathleen Bayless , who announced her ... Ali brings extensive financial management expertise to Synaptics, ...
Breaking Biology News(10 mins):Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Global Genetic Testing Market Outlook 2018 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2
(Date:5/21/2015)...  CytRx Corporation (NASDAQ: CYTR ), a ... today announced positive updated results from its ongoing ... treatment of unresectable glioblastoma multiforme (GBM), a deadly ... is designed to investigate the preliminary efficacy and ... progressed following prior treatment with surgery, radiation and ...
(Date:5/21/2015)... DUBLIN , May 20, 2015 Research ... announced the addition of the "2015 Global ... to their offering. The primary goal ... of flow cytometry instruments and reagents. Key information ... drive the selection of flow cytometers, predominantly used ...
(Date:5/21/2015)... Veolia’s environmental monitoring technology division, Endetec, ... agreement with VWR to distribute TECTA™ B16, an ... 160 years of experience, VWR, a leading global ... production facilities, has cultivated a value proposition delivering ... enable science. Endetec’s TECTA™ B16, combines proven ...
(Date:5/20/2015)... , May 20, 2015 ... presented preliminary data demonstrating the ability of the ... fibrosis (IPF) from other interstitial lung diseases (ILDs) ... the classifier,s potential to help thousands of patients ... ambiguity in IPF diagnosis – a frequent challenge ...
Breaking Biology Technology:CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Global Survey on Flow Cytometry Adoption Trends 2015 2Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5
Cached News: